Tuesday, 02 January 2024 12:17 GMT

Sudeep Pharma IPO Set To Open On November 21 GMP Signals Strong Listing Pop


(MENAFN- AsiaNet News)

Speciality chemicals maker Sudeep Pharma is gearing up for its stock market debut, with its IPO scheduled to open on Friday, November 21. The public issue includes a fresh offering of 16 lakh shares along with a sizeable offer for sale (OFS) of nearly 1.35 crore shares. Ahead of the launch, sentiment in the unofficial market appears upbeat, giving the IPO an early boost.

Grey Market Premium Points to Strong Demand

On Thursday morning, Sudeep Pharma's shares were trading with a grey market premium (GMP) of Rs 130, according to market trackers. At the IPO's upper price band of Rs 593 per share, this translates to an estimated listing price of around Rs 723 - nearly 22% higher than the issue price.

Key IPO Details

Here's a quick look at what investors need to know:

1. Price Band

The issue is priced between Rs 563 and Rs 593 per share.

2. IPO Dates

Subscription window: November 21 (Friday) to November 25 (Thursday).

3. Issue Size

The IPO consists of a 16 lakh-share fresh issue (raising Rs 95 crore) and an OFS of 1,34,90,726 shares by existing shareholders.

4. Reservation Structure

  • QIBs: 50%
  • Retail Investors: 35%
  • NIIs: 15%

5. Lot Size & Investment

  • One lot contains 25 shares.
  • Minimum investment: Rs 14,825 (1 lot at upper band)
  • Maximum for retail investors: 13 lots worth Rs 1,92,725

6. Lead Managers & Registrar

The IPO is being managed by ICICI Securities and IIFL Capital, with MUFG Intime as the registrar.

7. Allotment & Listing Timeline

  • Allotment: November 26 (Wednesday)
  • Shares/Refunds: November 27 (Thursday)
  • Listing on BSE & NSE: November 28 (Friday)

MENAFN20112025007385015968ID1110371360



AsiaNet News

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search